Summary

What this seminar is about:
Photocure in cooperation with HealthTalk welcomes you to a watch a webinar discussing bladder cancer in these challenging times of COVID-19 with a Nordic perspective. Anders Debes, Chief Medical Officer at Bærum hospital in Norway, together with HealthTalk's Editor in chief Hans Anderssen chair a conversation between:

  • Erik Skaaheim Haug, Vestfold Hospital, Norway
  • Thomas Thiel, Karolinska University Hospital, Sweden
  • Jørgen Bjerggaard Jensen, Aarhus University Hospital, Denmark
  • Mats Bläckberg, Helsingborgs Hospital, Sweden

Together they discussed relevant topics related to the treatment and follow- up of bladder cancer patients during the pandemic.

This is a recording of the seminar which took place 11.06.20.

Your hosts

Hans Anderssen
Hans Anderssen is co-founder and Editor in chief of HealthTalk.

MD. Anders Debes
PhD, at Bærum Hospital, Norway

Anders Debes is Chief Medical Officer at Bærum Hospital and responsible for the contingency plan during the pandemic. He has earlier worked as a urologist at several hospitals in Norway.

Guests

MD. Erik Skaaheim Haug
Vestfold Hospital, Norway

Erik Skaaheim Haug is a urologist at Vestfold Hospital in Norway and a researcher at the Department of Cancer Genetics and Informatics, Oslo University Hospital. He has a doctorate on results after surgery for abdominal aortic aneurysm and he is chairman of the Norwegian Urological Cancer Group, of the Norwegian bladder cancer group and of the advisory board of the Norwegian Prostate Cancer Registry.

MD. Tomas Thiel
Karolinska University Hospital, Sweden.

Tomas Thiel is a urologist at Karolinska University Hospital Stockholm/Huddinge, Sweden. He has a PhD in the field of Bladder Cancer – «Effects of BCG-treatment on urinary bladder cancer with focus on nitric oxide». He is a member of the regional bladder cancer group.

Professor, MD. Jørgen Bjerggaard Jensen
Aarhus University Hospital, Denmark.

Jørgen Bjerggaard Jensen is a professor and Head of clinical research in bladder cancer and robotic surgery at the Department of Urology, Aarhus University Hospital in Denmark. He is also Chairman of the Nordic Urothelial Cancer Group and Chief of Operation at BLACREST, in addition he is Head of urological research unit at the Department of Urology, Hospital of West Jutland

MD. Mats Bläckberg
Helsingborg Hospital, Sweden.

Mats Bläckberg is a urologist and Senior Consultant at the Department of Urology and Surgery, Helsingborg Hospital in Sweden. Member of SPESAK-group Urothelial cancer since 2001. Member of the board of Examiners, EBU oral exam since 2017. Ongoing research: Investigation of gene expression regarding correlation to treatment and prognosis in bladder cancer.